These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9102490)

  • 1. [The intensive treatment of multiple myeloma with support from hematopoietic progenitors].
    Paz-Ares L; Lahuerta J; Montes A
    Med Clin (Barc); 1997 Feb; 108(6):226-9. PubMed ID: 9102490
    [No Abstract]   [Full Text] [Related]  

  • 2. Tandem bone marrow transplantation in multiple myeloma.
    Musto P
    N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074004
    [No Abstract]   [Full Text] [Related]  

  • 3. [New trends in the therapy of myeloma].
    Jantunen E; Nousiainen T
    Duodecim; 2000; 116(9):937-9. PubMed ID: 11988994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progress in the study of autologous hematopoietic stem cell transplantation therapy of multiple myeloma].
    Zhang M; Son K
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):331-3. PubMed ID: 11243115
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
    Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
    Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of multiple myeloma.
    Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
    Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    López-Pérez R; García-Sanz R; González D; Balanzategui A; Chillón MC; Alaejos I; Mateos MV; Caballero MD; Corral M; Orfão A; González M; San Miguel JF
    Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple myeloma: intensive chemotherapy and autotransplantation].
    Jubert-Leleu MC
    Soins; 1994 Oct; (589):34-6, 38. PubMed ID: 7676295
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier.
    Kentos A; Vekemans M; Van Vooren JP; Lambermont M; Liesnard C; Feremans W; Farber CM
    Bone Marrow Transplant; 2002 Feb; 29(3):273-5. PubMed ID: 11859402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of autologous stem cell transplantation in the management of multiple myeloma.
    Fermand JP; Brechignac S
    Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.
    Vesole DH; Simic A; Lazarus HM
    Bone Marrow Transplant; 2001 Oct; 28(8):725-35. PubMed ID: 11781623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hematopoietic stem cell transplantation in multiple myeloma].
    Vela-Ojeda J; Ruiz-Esparza MA
    Rev Invest Clin; 2005; 57(2):305-13. PubMed ID: 16524072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma, 2004--one or two transplants?
    Stadtmauer EA
    N Engl J Med; 2003 Dec; 349(26):2551-3. PubMed ID: 14695416
    [No Abstract]   [Full Text] [Related]  

  • 15. Myeloma bone disease: pathogenesis and treatment.
    Roodman GD;
    Oncology (Williston Park); 2005 Jul; 19(8):983-4, 986. PubMed ID: 16131042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
    Dyson PG; Horvath N; Joshua D; Barrow L; Van Holst NG; Brown R; Gibson J; To LB
    Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to single-agent thalidomide and eligibility to undergo autotransplant for patients with multiple myeloma refractory to VAD.
    Milone JH; Prates V; Bordone J; Napal J; Garcia C
    Bone Marrow Transplant; 2003 Aug; 32(3):343. PubMed ID: 12858210
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.
    Mehta J; Singhal S
    Bone Marrow Transplant; 2007 Dec; 40(12):1101-14. PubMed ID: 17680020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-dose melphalan in patients with multiple myeloma].
    Moreau P; Le Bonniec M; Harousseau JL
    Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose therapy of multiple myeloma with autologous hematopoietic stem cell transplantation and subsequent maintenance therapy with interferon alfa versus interferon alfa and dexamethasone--a randomized clinical study "4W"].
    Mareschová I
    Vnitr Lek; 1997 May; 43(5):345. PubMed ID: 9601862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.